The Future of Precision Medicine
Featuring: Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree
Phase I Study of AMG 510
Abstract 528PD: Correlative analysis of CCTG CO.26
Abstract LBA30_PR: Correlative analysis of IDEA-FRANCE phase III trial
Abstract: LBA15_PR
TRK Fusion Updates
Therapeutic drug monitoring of oral anticancer drugs
Featuring: Dr. Steffie Groenland Dr. Neeltje Steeghs
Durvalumab activity in previously treated patients
Featuring: Dr. Siddharth Sheth
MAGE-A4 Trial
Featuring: Dr. Brian Van Tine
FIGHT-202 Study
Featuring: Dr. Arndt Vogel
CCGA Study
Featuring: Dr. Geoffrey Oxnard
Sarcoma
Featuring: Dr. Christine Simmons
Novel Immune Therapy Approaches: From Immune Checkpoint Inhibitors to Adoptive T-Cell Transfer
Featuring: Dr. Michael Smylie
Canadian Achievements in Cancer Research
Featuring: Dr. Mark Clemons
Featuring: Dr. Lisa Barbera
Evidence For NTRK Inhibitors
Featuring: Dr. David Hong & Dr. Adrian Sacher
Supportive Care
Featuring: Dr. Elie Kassouf
New Technologies in Cancer Care
Featuring: Dr. John Kildea
Broad Indications for Small Molecular Inhibitors, and DNA repair deficiency
Featuring: Dr. Gwyn Bebb Dr. Daniel Renouf Dr. Sebastien Hotte
Broad Indications for Immunotherapy
End of Life Quality at Minority-Serving Cancer Centers
Featuring: Dr. Garrett Wasp
Monteluksat and Rupatadine and their combination with Rituximab
Featuring: Dr. Rouslan Kotchetkov
Routine ESAS use on OS
What is the Role of 'Big Data' in Cancer Care
Featuring: Cindy Perettie, CEO, Foundation Medicine Inc.
Panel Discussion
Future of Precision Medicine
Featuring: Dr. Trevor Pugh
The Impact of Artificial Intelligence and 'Big Data' on Health Policy
Featuring: Dr. Catherine Stinson
BioInformatics and the Role of Artificial Intelligence in Cancer Care
Featuring: Dr. Benjamin Haibe-Kains
How is Technology Impacting Drug Development in Oncology
Featuring: Dr. Leigh Revers
Lunch Presentation - Biosimilars in Oncology
Featuring: Dr. Anil Abraham Joy Dr. Sandeep Sehdev
Special Session: Best of Real World Evidence in Oncology
Featuring: Dr. Winson Cheung
Best of Oncology East 2018
November 30th, 2018 Toronto, ON
Satellite Symposium - Lunch Presentation - Chemotherapy-Induced Nausea and Vomiting — A Case-Based Presentation
Featuring: Dr. Kasia Jerzak Shikha Lawrence
Biomarkers to Guide Treatment Decision: PDL-1 and Beyond
Featuring: Dr. Ming Tsao
CAR T-Cell Therapy: Are we driving in the fast lane?
Featuring: Dr. Christine Chen
Innovating Clinical Trial Designs to accelerate Immune-Therapies in Cancer
Featuring: Dr. Martin Smoragiewicz
Combination Strategies to Enhance Efficacy
Featuring: Dr. Adrian Sacher
Featuring: Dr. Martin Smoragiewicz Dr. Christine Chen Dr. Adrian Sacher
The Future of IO Therapies Beyond Checkpoint Inhibitors
Featuring: Dr. Rosalyn Juergens
Featuring: Dr. Natasha Leighl Dr. Henry Conter Dr. Sunil Verma
The Canadian Advantage – Role of Real World Evidence and Opportunities to Enhance Value of IO Therapies in Canada
Featuring: Dr. Natasha Leighl
Case Studies and Panel Discussion
Featuring: Dr. Andrew Robinson Dr. Nancy Nixon Dr. David Hogg Dr. Teresa Petrella
Role of Multi-Disciplinary Team in Management of Patients on IO Therapies
Featuring: Dr. David Hogg
Keynote Lecture: Personalizing Immune-Therapies and Understanding resistance
Featuring: Dr. David Carbone
Canadian Immuno-Oncology Summit 2018
November 1st, 2018 Toronto, ON
Initial of BMS-986158 in Phase 1 dose escalation
Featuring: Dr. John Hilton
PHOENIX Study
Featuring: Dr. Ali Alkan
AMC303
Featuring: Dr. Emiliano Calvo
Probiotics in Chemo-induced Diarrhea
Featuring: Dr. Atul Sharma
NETSARC Study
Featuring: Dr. Jean-Yves Blay
Featuring: Dr. David Carbone Dr. Rosalyn Juergens Dr. Teresa Petrella Dr. Ming Tsao Dr. Sunil Verma
Cost of integrating Immuno-Oncology Therapy in Clinical Practice: Are we prepared?
Featuring: Dr. Henry Conter
Special Session: Precision Oncology
Featuring: Dr. Gwyn Bebb
Lunch Symposium - New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting
Featuring: Dr. Jay Easaw and Roland Coppens
New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting
Featuring: Dr. Jay Easaw & Mark Pasetka
Featuring: Dr. Nathaniel Bouganim and Veronique Savard
Best of ASCO Montreal 2018 - Supportive Care
Proactive Symptom Assessment Effect on Care Outcomes
Featuring: Dr. Manali Patel
HER2-Targeted Topo Inhibition in HER2+ Solid Tumours
Featuring: Dr. Hiroji Iwata
PIVOT Trial
Featuring: Dr. Adi Diab
Bidirectional Targeting of PD-L1 and TNFb in HPV-Associated Cancers
Featuring: Dr. Julius Strauss
MATCH Study
Featuring: Dr. Young Kwang Chae
Duplicate of Proactive Symptom Assessment Effect on Care Outcomes
Duplicate of HER2-Targeted Topo Inhibition in HER2+ Solid Tumours
Duplicate of PIVOT Trial
Duplicate of Bidirectional Targeting of PD-L1 and TNFb in HPV-Associated Cancers
Duplicate of MATCH Study
Targeted Antibody Conjugate in HER2 Amplified Cancers
Featuring: Dr. Bob Li
Duplicate of Targeted Antibody Conjugate in HER2 Amplified Cancers
Panel Discussion on Biosimilars
Featuring: Dr. Scott Berry Flay Charbonneau Alexandra Chambers Dr. Andrea Eisen Dr. Hal Hirte Dr. Sunil Verma Dr. Sandy Sehdev Barry Stein
From Bench to Bedside with Bevacizumab Biosimilars
Featuring: Dr. Scott Berry
Biosimilars in Breast Cancer: Clinical Implications
Featuring: Dr. Sunil Verma
Update from CADTH on Biosimilars
Featuring: Alexandra Chambers Director, pan Canadian Oncology Drug Review (pCODR), CADTH
Understanding the Science of Biosimilars: How are they different from emerging drugs? What are they and how are they created?
Featuring: Dr. Sandy Sehdev
Video 1: Introduction to Biosimilars
Video 4: Biosimilars in Clinical Practice Panel Discussion
Featuring: Dr. Scott Berry Dr. Sunil Verma Dr. Sandy Sehdev
Video 3: Bevacizumab Biosimilars Clinical Considerations
Video 2: Trastuzumab Biosimilars Clinical Considerations
Special Session - Biosimilars
From Bench to Bedside: Translating New Knowledge to Drug Development
Featuring: Dr. Linh Nguyen
From Bedside to Bench – Understanding Immune-Therapy Resistance
Featuring: Dr. Jason Luke
Biomarkers to Guide IO Therapy
PD-L1 Testing in Routine Practice
Management of Immune-Therapy Related Adverse Events
Utilizing Immuno-Oncology Therapies in Clinical Practice
Beyond Checkpoint Inhibitors – Novel IO Therapies and IO-IO Combination Therapy
IO Combination with Chemotherapy, Radiation and Targeted Therapies
Featuring: Dr. Heather McArthur
Denosumab in Giant Cell Tumor of Bone
Featuring: Dr. Emanuela Palmerini
Nivolumab & ISA 101 HPV vaccine in incurable HPV-16+ cancer
Featuring: Dr. Erminia Massarelli
Antivascular Tumour Therapy
Featuring: Dr. Urban Emmenegger
Molecular Targeting and Drug Design
Featuring: Dr. Aaron Schimmer
Updates from Chicago 2017: Other Topics
June 3-7, 2017 Chicago, USA
Featuring: Dr. Monika Kryzyzanowska
Featuring: Sierra Cheng
Best of ASCO Montreal 2017 - Canadian Abstracts
Featuring: Dr. Kim Ma
Health Sciences Research: Patient Reported Outcomes
Featuring: Dr. Robert Olson
Debate - Medical Assistance in Dying
Featuring: Dr. Charles Blanke Dr. Howard Lim
Debate on Second Entry Biologic
Featuring: PRO: Dr. Leigh Revers CON: Dr. Sandy Sehdev
Promises and Challenges in Immuno-Oncology
Featuring: Dr. Réjean Lapointe
Principles of Immuno-Oncology - A Clinician Perspective
Featuring: Dr. Omid Hamid
MCBS in rare tumor entities
Featuring: Dr. Barbara Kiesewetter
89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors
Featuring: Dr. Catharina Menke-van der Houven van Oordt
BAY 1163877
Featuring: Dr. Markus Joerger
PRIME-NET study
Featuring: Dr. Sara Pusceddu
Tumour gene expression data and clinical decision-making for patients with advanced cancers
Featuring: Dr. Janessa Laskin
Trabectedin vs best supportive care in pretreated advanced soft tissue sarcoma
Featuring: Dr. Axel Le Cesne
Lunch Symposium: Urothelial Cancers Management
Featuring: Dr. Robert Dreicer
Round-Table Discussion on Pharmacoeconomics
Featuring: Dr. Kathleen Barnard, Dr. Brent Fraser, Dr. Jaclyn Beca, Dr. Marcus Butler & Dr. Ilias Illiopolous Chair: Dr. Sunil Verma
Keynote Presentation: Future Applications in Immuno-Oncology
A New Way of Treating: Multidisciplinary Approach in Immuno-Therapy
Panel Discussion: Redefining Success in Oncology
Featuring: Dr. Jason Luke, Kathleen Barnard, Christina Sit & Dr. Marcus Butler Moderator: Dr. Rosalyn Juergens
Plenary Session Q&A
Featuring: Dr. Jason Luke, Kathleen Barnard, Dr. Marcus Butler & Dr. Linh Nguyen Chair: Dr. Sunil Verma
Immuno-Oncology: From Concept to Reality
Beyond the Curve
Featuring: Kathleen Barnard
Principles of Immuno-Oncology - An Immunologist Perspective
Lorazepam as an Adjuvant to Haloperidol for Agitated Delirium at the End of Life
Featuring: Dr. David Hui
CALM Trial
Featuring: Dr. Gary Rodin
Psychological Intervention on the Fear of Cancer
Featuring: Dr. Jane Beith
Korean Red Ginseng to Improve Cancer-Related Fatigue
Featuring: Dr. Yeul Hong Kim
Immune response, safety, and survival impact in soft tissue sarcomas
Featuring: Dr. Neeta Somaiah
Laboratory Methods in Translational Oncology Research
Featuring: Dr. Kelsie Thu
Keynote Address: The Important Molecular/ Translational Endpoints In Clinical Trials
Featuring: Dr. Kathy Pritchard
DNA Repair and Epigenetics
Oncogenes/Tumour Suppressor Genes
Featuring: Dr. Neesha Dhani
Signaling Pathways
Featuring: Dr. Tony Mutsaers
Cell Cycle and Survival Mechanisms
Featuring: Dr. David Cescon
Stem Cells
Featuring: Dr. Catherine O'Brien
Tumour Immunobiology/ Immunotherapy
Featuring: Dr. Marcus Butler
Invasion Metastasis
Featuring: Dr. Richard Hill
Molecular Pathology
An Introduction to Biomarkers
Featuring: Dr. Phil Bedard
Molecular Pharmacology/ Epidemiology
Featuring: Dr. Geoff Liu
Best of ASCO Montreal 2016 - Neuroendocrine Cancers
Featuring: Dr. Simron Singh
Highlights on Cancer and the Heart ASCO 2016
Featuring: Dr. Susan Dent
Phase I study of sapacitabine and seliciclib
Featuring: Dr. Sara Tolaney
Comorbidities & Risk of Peripheral Neuropathy in SWOG Trials
Featuring: Dr. Dawn Hershman
Phase 1B Study of BGJ398 with BYL719
Featuring: Dr. David Hyman
Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy
Featuring: Dr. Ian Kleckner
Precision Medicine in Cancer Care
Featuring: Dr. Jonathan Trent
Panel Discussion: Cancer Care in 2025
Perspective from BC Cancer Agency
Featuring: Dr. Malcolm Moore
Perspective from Lung Cancer Canada
Featuring: Dr. Paul Wheatley-Price
Perspective from Colorectal Cancer Association of Canada
Featuring: Mr. Barry Stein
Perspective from CAMO
Featuring: Dr. Christopher Lee
Perspective from CARO
Featuring: Dr. Gerard Morton
Perspective from CSSO
Featuring: Dr. Jay Engel
Perspective from Innovative Medicines Canada
Featuring: Mr. Marc Zarenda
Webinar Archive: NETs Speaker Tour Montreal
NETs Case Study
Featuring: Dr. Petr Kavan
NETs in Québec
Featuring: Dr. Albert Moghrabi
What's New with NETs?
Best of Oncology West 2017 - Supportive Care
Featuring: Dr. Corey Metcalf
Webinar Archive: NETs Speaker Tour Vancouver
Featuring: Dr. Simron Singh Dr. John Paul McGhie Dr. Hagen Kennecke
NET Case Study
Featuring: Dr. Hagen Kennecke
BC Perspective on NETs
Featuring: Dr. John Paul McGhie
What's New With NETs?
Webinar Archive: NETs Speaker Tour Toronto
Featuring: Dr. Simron Singh Dr. Calvin Law Dr. Tim Asmis
Neuroendocrine Cancers: What's New With NETs?
Advanced NETs
Featuring: Dr. Calvin Law
Non-Functioning Small pNETS
Featuring: Dr. Tim Asmis
